Hiroaki Satoh

5.7k total citations
315 papers, 3.9k citations indexed

About

Hiroaki Satoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroaki Satoh has authored 315 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Pulmonary and Respiratory Medicine, 130 papers in Oncology and 52 papers in Surgery. Recurrent topics in Hiroaki Satoh's work include Lung Cancer Treatments and Mutations (80 papers), Lung Cancer Diagnosis and Treatment (59 papers) and Lung Cancer Research Studies (59 papers). Hiroaki Satoh is often cited by papers focused on Lung Cancer Treatments and Mutations (80 papers), Lung Cancer Diagnosis and Treatment (59 papers) and Lung Cancer Research Studies (59 papers). Hiroaki Satoh collaborates with scholars based in Japan, United States and Taiwan. Hiroaki Satoh's co-authors include Hiroichi Ishikawa, Koichi Kurishima, Morio Ohtsuka, Katsunori Kagohashi, Nobuyuki Hizawa, Kiyohisa Sekizawa, Hiroshi Kamma, Tomohiro Tamura, Kensuke Nakazawa and Yukio Ishii and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gut.

In The Last Decade

Hiroaki Satoh

281 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Satoh Japan 29 2.0k 1.2k 949 455 437 315 3.9k
Rudolf M. Huber Germany 38 3.3k 1.7× 1.8k 1.5× 1.2k 1.2× 411 0.9× 431 1.0× 221 5.4k
B. Milleron France 38 3.2k 1.6× 2.4k 2.0× 924 1.0× 751 1.7× 472 1.1× 225 5.5k
Johannes M.G. Bonfrèr Netherlands 33 994 0.5× 1.4k 1.1× 1.1k 1.2× 757 1.7× 467 1.1× 67 4.1k
Carol J. Etzel United States 37 1.1k 0.6× 993 0.8× 1.4k 1.5× 452 1.0× 664 1.5× 128 4.6k
Navneet Singh India 30 2.0k 1.0× 1.3k 1.0× 963 1.0× 382 0.8× 402 0.9× 247 4.2k
Young‐Chul Kim South Korea 33 1.9k 0.9× 2.2k 1.8× 878 0.9× 406 0.9× 370 0.8× 241 4.1k
Erik H.F.M. van der Heijden Netherlands 32 3.1k 1.6× 1.7k 1.4× 1.4k 1.4× 358 0.8× 858 2.0× 121 6.1k
Domenico Galetta Italy 28 1.5k 0.8× 1.3k 1.1× 374 0.4× 352 0.8× 284 0.6× 175 2.8k
Masafumi Yamaguchi Japan 33 2.7k 1.3× 1.0k 0.8× 482 0.5× 250 0.5× 498 1.1× 186 3.8k
Olfred Hansen Denmark 37 1.9k 1.0× 1.1k 0.9× 769 0.8× 289 0.6× 1.0k 2.4× 174 4.6k

Countries citing papers authored by Hiroaki Satoh

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Satoh more than expected).

Fields of papers citing papers by Hiroaki Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Satoh. The network helps show where Hiroaki Satoh may publish in the future.

Co-authorship network of co-authors of Hiroaki Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Satoh. A scholar is included among the top collaborators of Hiroaki Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Satoh. Hiroaki Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatori, Takashi, Toshihiro Shiozawa, Hirofumi Sakurai, et al.. (2024). Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study. Current Oncology. 31(11). 6502–6511.
2.
Satoh, Hiroaki, et al.. (2022). Late-onset pulmonary and cardiac toxicities in a patient treated with immune checkpoint inhibitor monotherapy. Klinicka onkologie. 35(2). 150–154. 2 indexed citations
3.
Kawai, Hitomi, et al.. (2020). Metachronous Isolated Contralateral Lung Metastasis from Pulmonary Adenosquamous Carcinoma with EGFR Mutation. SHILAP Revista de lepidopterología. 63(3). 141–144. 1 indexed citations
4.
Sato, Shinya, Hideyasu Yamada, Kunihiko Miyazaki, et al.. (2019). Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit. Journal of General and Family Medicine. 20(3). 101–106. 1 indexed citations
5.
Watanabe, Hiroko, Tomohiro Tamura, Katsunori Kagohashi, et al.. (2015). Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report. Experimental and Therapeutic Medicine. 10(1). 386–388. 3 indexed citations
6.
Satoh, Hiroaki, Katsunori Kagohashi, Gen Ohara, et al.. (2012). [A case of thymoma and Mycobacterium intracellulare infection].. PubMed. 87(11). 701–5. 2 indexed citations
7.
Satoh, Hiroaki, et al.. (2010). 1P1-F24 Robot Design in the Robot Triathlon-a Robot Contest in Hokkaido. The Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec). 2010(0). _1P1–F24_1. 1 indexed citations
8.
Homma, Shinsuke, Yukio Ishii, Yuko Morishima, et al.. (2009). Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer. Clinical Cancer Research. 15(10). 3423–3432. 369 indexed citations
9.
Kurishima, Koichi, Hiroaki Satoh, Katsunori Kagohashi, et al.. (2009). Patients With Lung Cancer With Metachronous or Synchronous Gastric Cancer. Clinical Lung Cancer. 10(6). 422–425. 5 indexed citations
10.
Satoh, Hiroaki, Hiroichi Ishikawa, Gen Ohara, et al.. (2008). Long-term survivors after chemotherapy in advanced non-small cell lung cancer.. PubMed. 27(6C). 4457–60. 23 indexed citations
11.
Satoh, Hiroaki, et al.. (2007). Psychotropic drugs for terminally ill patients with respiratory disease.. PubMed. 55(1). 5–10. 2 indexed citations
12.
Kagohashi, Katsunori, Hiroaki Satoh, Koichi Kurishima, Hiroichi Ishikawa, & Morio Ohtsuka. (2006). Body mass index and lung cancer risk in never smokers. Radiology and Oncology. 40(4). 4 indexed citations
13.
Kurishima, Koichi, Hiroaki Satoh, Shinsuke Homma, et al.. (2005). Multiple primary malignancies in patients with lung cancer. Radiology and Oncology. 39(1). 5 indexed citations
14.
Kaneko, Yoshiko, Norihiro Haraguchi, Takahide Kodama, et al.. (2003). Endobronchial metastasis as first manifestation of renal cell carcinoma. Radiology and Oncology. 37(4). 1 indexed citations
15.
Satoh, Hiroaki, Morio Ohtsuka, & Kiyohisa Sekizawa. (2003). Endobronchial Actinomycosis and Foreign Body. CHEST Journal. 123(2). 656–657. 3 indexed citations
16.
Kagohashi, Katsunori, Hiroaki Satoh, Hiroichi Ishikawa, Morio Ohtsuka, & Kiyohisa Sekizawa. (2003). BONE METASTASIS AS THE FIRST MANIFESTATION OF LUNG CANCER. International Journal of Clinical Practice. 57(3). 184–186. 16 indexed citations
17.
Ishikawa, Hiroichi, Hiroaki Satoh, Y. Yamashita, et al.. (1998). Curved chest tube for drainage of malignant pleural effusion. Respiratory Medicine. 92(4). 633–637. 4 indexed citations
18.
Ito, Chikako, I. Satoh, Katsumi Miyazaki, et al.. (1997). Reducing nurses'. Workload using a computerized nursing support system linked to the hospital information system.. PubMed. 46. 527–32. 4 indexed citations
19.
Ishikawa, Hiroichi, Hiroaki Satoh, Takashi Naito, et al.. (1996). Lung Cancer in Ibaraki Prefecture: Summary of Clinical Assessment in 1100 Cases, with Special Reference to The Reasons for Detection of the Cancer.. Haigan. 36(7). 885–891. 1 indexed citations
20.
Satoh, Hiroaki, et al.. (1991). Correlation between Carcass Characteristics and Plasma Insulin-like Growth Factor-I Level in Japanese Black Beef Cattle. Nihon Chikusan Gakkaiho. 62(8). 774–776. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudolf M. Huber Breakdown of academic impact, for papers by B. Milleron Breakdown of academic impact, for papers by Johannes M.G. Bonfrèr Breakdown of academic impact, for papers by Carol J. Etzel Breakdown of academic impact, for papers by Navneet Singh Breakdown of academic impact, for papers by Young‐Chul Kim Breakdown of academic impact, for papers by Erik H.F.M. van der Heijden Breakdown of academic impact, for papers by Domenico Galetta Breakdown of academic impact, for papers by Masafumi Yamaguchi Breakdown of academic impact, for papers by Olfred Hansen
Rankless by CCL
2026